Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-084296

Options or other derivatives

  • Director acquired 29,305 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Link David Charles Director 2024-07-15 Grant or award · Stock Option (right to buy) +20,000 20,000 D
Link David Charles Director 2024-07-15 Grant or award · Stock Option (right to buy) +9,305 9,305 D
Loading xslF345X05/ownership.xml…